Skip to content

NMN

A direct NAD+ precursor (one step from NAD+) popular for cellular energy and longevity — an alternative to NR for raising NAD+.

  • CategoryLongevity & Antioxidants
  • FormNicotinamide Mononucleotide
  • EvidenceClinical trials on file

Where to get NMN

iHerb
Nicotinamide Mononucleotide

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesNicotinamide mononucleotide is one enzymatic step from nicotinamide adenine dinucleotide, and that fact is the entire marketing claim and also the weakest part of it. Nicotinamide mononucleotide adenylyltransferase converts it to NAD+ in a single reaction.
  • Who it is forNAD+, energy and metabolic-aging experimenters (an NR alternative).
  • What to watchWell tolerated in the trials to date — nausea, flushing and headache are the usual reports.

How NMN works

NMN sits one enzymatic step from NAD+ — NMN adenylyltransferase converts it directly — which is the basis for the claim that it's the more efficient precursor. The genuine scientific argument is whether it enters cells intact at all: NMN is phosphorylated and therefore not obviously membrane-permeable, and much evidence suggests it's dephosphorylated to nicotinamide riboside outside the cell, absorbed, then re-phosphorylated inside.

Read the rest of how it works

A dedicated NMN transporter has been proposed but remains debated. If the conversion route is real, NMN and NR are closer to the same product than the marketing suggests.

NMN: serving, timing and spacing

Suggested serving
250–1,000 mg daily.
How often
Daily
When
Morning, on an empty stomach

General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.

Good to know: NR (Thorne carries it) and NMN both raise NAD+ — NMN is one step closer, NR has more human trials. Either works.

Research on NMN4 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • RCTs show NMN raises blood NAD+ and improved some measures of muscle/aerobic performance and insulin sensitivity.

  • Human functional-outcome data are growing but still early.

Correlative data

  • NAD+ declines with age, tracking with metabolic and mitochondrial aging.

Theoretical / extrapolated benefits

  • The NAD+/sirtuin longevity promise is strong in animals; human healthspan outcomes remain unproven. (Note: NMN's supplement status has faced regulatory uncertainty in the US.)

Sources read for this page

  • Yi L. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience 2023 · PMID 36482258
  • Katayoshi T. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep 2023 · PMID 36797393
  • Zhang J. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Crit Rev Food Sci Nutr 2024 · PMID 39116016
  • Kuerec AH. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration. Mech Ageing Dev 2024 · PMID 38430946
  • Fukamizu Y. Safety evaluation of beta-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep 2022 · PMID 36002548
  • Yang W. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients 2026 · PMID 42514320
  • Tretowicz MM. Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nat Metab 2026 · PMID 42135539
  • Cantó C. NAD+ Precursors: A Questionable Redundancy. Metabolites 2022 · PMID 35888754
  • Trammell SA, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications 2016 · PMID 27721479

NMN, the deep readThe mechanism, cell to human, which form, how you would know

What NMN actually does

Nicotinamide mononucleotide is one enzymatic step from nicotinamide adenine dinucleotide, and that fact is the entire marketing claim and also the weakest part of it. Nicotinamide mononucleotide adenylyltransferase converts it to NAD+ in a single reaction. The problem is the step before: NMN is a phosphorylated nucleotide of about 334 daltons, and a charged phosphate is not a structure that crosses membranes freely.

Which is why the transport question is the mechanistic center of this page. The route most consistent with the data is dephosphorylation to nicotinamide riboside at the cell surface, uptake, and rephosphorylation inside -- meaning the molecule that enters is arguably not the molecule that was swallowed. The precursor literature has framed this as a question of whether the various NAD+ precursors are meaningfully distinct or redundant Cantó 2022.

The comparison molecule has cleaner human data on exactly this point. Nicotinamide riboside was shown to be orally bioavailable in mice and humans with the exposure demonstrated rather than inferred Trammell 2016. That is the standard NMN has to meet, and it is why 'one step closer' is a statement about a metabolic map rather than about a person.

The clock here is not a half-life, it is a turnover rate, and it is fast. Cellular NAD+ is consumed continuously by PARPs, sirtuins and CD38 and resynthesized through the salvage pathway; the pool recycles many times a day. A once-daily capsule is a brief input into a rapidly turning pool, which is a different proposition from raising a slow reservoir.

Cell, rodent, human — and where it stops

The human trials now exist, and what they measure is the interesting part.

What has been measured in people. A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial examined efficacy and safety in healthy middle-aged adults Yi 2023. A randomized, double-blind, placebo-controlled trial measured NAD metabolism and arterial stiffness after long-term supplementation Katayoshi 2023. Safety of oral administration has been evaluated in healthy adult men and women Fukamizu 2022, and systematic reviews with meta-analysis have pooled the glucose and lipid outcomes Zhang 2024 and the safety and metabolism-related outcomes Yang 2026.

The first obstacle is that the primary endpoint is usually the precursor's own marker. Blood NAD+ rising is the demonstration that the pathway is intact, not that anything downstream changed. Work toward personalized supplementation is explicitly organized around NAD concentration as the thing being targeted Kuerec 2024, which is an honest framing and also a surrogate one.

The second obstacle is that the marker may not vary the way the field assumed. Human whole-blood NAD+ levels have been reported not to vary with age or with lifestyle interventions Tretowicz 2026. If the deficit the product is sold to correct is not visible in the compartment being measured, the rationale needs restating rather than repeating.

What would close the gap. Report tissue NAD+ rather than whole blood, pre-specify a functional endpoint, and compare NMN directly against nicotinamide riboside and against plain nicotinamide at matched molar doses Cantó 2022 Trammell 2016.

NMN — which form, and does it matter

The comparison that matters is not between brands of NMN, it is between NMN, nicotinamide riboside and nicotinamide. All three feed the same salvage pathway. The precursor review asks directly whether the distinctions are meaningful or redundant Cantó 2022, and nicotinamide riboside is the one with a demonstrated human oral bioavailability study Trammell 2016.

Sublingual, liposomal and enteric forms all exist because of the phosphate. Each is an attempt to solve the same problem -- getting a charged nucleotide somewhere useful -- and none of them has a published head-to-head human exposure comparison against plain oral powder Kuerec 2024.

Purity is a live issue in this category. NMN is synthesized rather than extracted, and a certificate of analysis naming the assay method is the only thing distinguishing a tested product from an untested one. That matters more here than in a botanical because there is no marker chemistry to fall back on.

The regulatory position is part of the form question in the United States. The Food and Drug Administration has taken the view that NMN is excluded from the dietary supplement definition because it was investigated as a drug, so availability and labeling may change. No filed panel for an NMN product has been read into supplements_data.BLENDS on this site.

What would have to be true, and how you would know it was not

1. The marker prediction, at 8 weeks. Whole-blood NAD+ at baseline and 8 weeks at 500 mg daily. Predict a rise, because that is the reproducible finding across the trials Yi 2023 Katayoshi 2023. Predict also that this tells you the pathway works and nothing about a clinical outcome.

2. The baseline prediction, which cuts against the anti-aging pitch. Predict that baseline whole-blood NAD+ does not correlate with age in a healthy sample, because that is the reported finding Tretowicz 2026. A product sold to reverse an age-related decline should be able to demonstrate the decline first.

3. The functional prediction, at 12 weeks. Fasting glucose and insulin with a calculated insulin sensitivity index, plus a six-minute walk or a grip measurement. Predict small and inconsistent changes, which is what the pooled analyses of glucose and lipid metabolism describe Zhang 2024 Yang 2026.

4. The vascular prediction. Pulse wave velocity at baseline and after long-term dosing, which is the endpoint the arterial stiffness trial used Katayoshi 2023.

5. The precursor falsification. Randomize NMN against nicotinamide riboside against plain nicotinamide at matched molar doses, measuring blood NAD+ and one functional endpoint. Prediction: the three are hard to separate on the marker Cantó 2022 Trammell 2016. If NMN clearly wins, the premium is justified and this section is wrong.

What nobody has tested yet

Nobody has demonstrated intact NMN uptake in human tissue. The transport route is inferred, and the human oral bioavailability demonstration that exists belongs to nicotinamide riboside Trammell 2016.

Nobody has measured tissue NAD+ in a supplementation trial. Whole blood is the accessible compartment and it may not be the relevant one Tretowicz 2026 Kuerec 2024.

Nobody has run it for years. The trials are weeks to months Yi 2023 Fukamizu 2022 Yang 2026, so nothing can be said about daily use over a decade.

And nobody has resolved the proliferation question. NAD+ precursors support cell proliferation, and whether that matters in somebody with an undiagnosed malignancy is unresolved rather than settled in either direction Cantó 2022.

NMN — its own safety story, not its category's

Short-term tolerability is good and the honest statement is about the length of the record rather than its content. Safety evaluation of oral administration in healthy adults reported it well tolerated Fukamizu 2022, and the pooled safety and metabolism-related outcomes reach the same conclusion across the available trials Yang 2026. Nausea, flushing and headache are the usual reports.

The theoretical concern worth stating plainly is proliferation. NAD+ is required for the DNA repair and metabolic machinery of dividing cells, so a precursor supports proliferation in general rather than selectively Cantó 2022. Whether that matters in a person with an undiagnosed cancer has not been studied, which is a gap rather than an alarm and is the reason it belongs on the page.

The regulatory status is contested in the United States. The Food and Drug Administration's position that NMN is excluded from the supplement definition means availability, labeling and enforcement may change. That is a purchasing consideration and not a safety finding, and confusing the two helps nobody.

What has not been established. No trial has run for years Yi 2023 Katayoshi 2023, none has enrolled pregnancy, and none has characterized interactions with medication. Anyone with a cancer history should be making this decision with their oncology team. Nothing here is medical advice or a diagnosis, and none of these statements has been evaluated by the Food and Drug Administration.

NMN safety basics3 points of its own, standing advice

Its own safety story

  • Well tolerated in the trials to date — nausea, flushing and headache are the usual reports.
  • Its US regulatory status is contested: the FDA has taken the position that NMN is excluded from the supplement definition because it was investigated as a drug. Availability may change.
  • The theoretical concern worth stating: NAD+ precursors fuel cell proliferation, and whether that matters in someone with an undiagnosed cancer is unresolved rather than settled either way.

Standing advice: long-term use

  • Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade.

The same on every page it applies to.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run5 tests in one order, code CAMERON

NMN FAQ5 common questions

What is NMN?
A direct NAD+ precursor (one step from NAD+) popular for cellular energy and longevity — an alternative to NR for raising NAD+.
What is the suggested dose of NMN?
250–1,000 mg daily. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is NMN for?
NAD+, energy and metabolic-aging experimenters (an NR alternative).
Which labs show whether NMN is doing anything?
hs-CRP (High-Sensitivity C-Reactive Protein), HbA1c (Hemoglobin A1c), Comprehensive Metabolic Panel (CMP), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), Fasting Insulin. Draw a baseline before you start, then recheck.
Where can I buy NMN?
Coach Cam sources NMN from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what NMN is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What NMN is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What NMN is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • NMN in your full stack: what it runs with, and what it cancels out
  • Its place in 1 Protocol Blueprint (Longevity), week by week
  • The retest plan: hs-CRP (High-Sensitivity C-Reactive Protein) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool